Viewing Study NCT01430351


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-06-17 @ 3:30 PM
Study NCT ID: NCT01430351
Status: TERMINATED
Last Update Posted: 2025-05-07
First Post: 2011-09-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioblastoma View
None Gliosarcoma View
None Supratentorial Glioblastoma View
Keywords: